InsidersTradesSigma
Track the Augmedix, Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Augmedix, Inc. has published 76 insider filings. The latest transaction was filed on 4 October 2024 (Disposition). Among the most active insiders: Shakil Ian. All data is free.
76
Insider Decl.
n/a
Thresholds
€9m
6 ops.
Buy Volume
€40m
27 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 October 2024
Declarations76 total
162,583 shares@ US$2.35100.0% of flowCommon StockSEC:0001213900-24-085379:0
74,230 shares@ US$2.35100.0% of flowCommon StockSEC:0001213900-24-085351:0
21,598 shares@ US$2.35100.0% of flowCommon StockSEC:0001213900-24-085362:0
41,461 shares@ US$2.3590.5% of flowCommon StockSEC:0001104659-24-106311:0
124,126.75 shares@ US$2.3566.1% of flowCommon StockSEC:0001213900-24-085353:0
135,795 shares@ US$2.3573.2% of flowCommon StockSEC:0001213900-24-085356:0
7,701 shares@ US$2.352.2% of flowCommon StockSEC:0001213900-24-085345:0
5,844 shares@ US$2.35100.0% of flowCommon StockSEC:0001213900-24-085370:0
20,295 shares@ US$2.35100.0% of flowCommon StockSEC:0001213900-24-085366:0
74,230 shares@ US$2.35100.0% of flowCommon StockSEC:0001213900-24-085349:0
5,844 shares@ US$2.35100.0% of flowCommon StockSEC:0001213900-24-085346:0
64,748 shares@ US$2.35100.0% of flowCommon StockSEC:0001213900-24-085342:0
16,421,788 shares@ US$2.3559.5% of flowCommon StockSEC:0001104659-24-106315:0
6,250 sharesCommon StockSEC:0001213900-24-070867:0
3,750 sharesCommon StockSEC:0001213900-24-070870:0
6,250 sharesCommon StockSEC:0001213900-24-070865:0
4,687 sharesCommon StockSEC:0001213900-24-070863:0
9,375 sharesCommon StockSEC:0001213900-24-070862:0
4,687 sharesCommon StockSEC:0001213900-24-070868:0
3,750 sharesCommon StockSEC:0001213900-24-070875:0
1,322 shares0Common StockSEC:0001013762-24-002827:0
21,598 sharesCommon StockSEC:0001213900-24-061516:0
21,598 sharesCommon StockSEC:0001213900-24-061519:0
21,598 sharesCommon StockSEC:0001213900-24-061517:0
21,598 sharesCommon StockSEC:0001213900-24-061515:0
25 of 76 declarations
关于 Augmedix, Inc.
在竞争方面，Augmedix 在竞争激烈的医疗保健 IT 领域运营，面临来自大型 EHR 供应商、外包文档提供商和新型环境抄写 AI 平台的压力。其差异化基于软件、服务交付和工作流程集成，特别是针对企业医疗系统。最近的一个重要里程碑是 2024 年 7 月宣布与 Commure 达成最终协议，以约 139 million 美元的现金交易被收购，随后于 2024 年 10 月完成交易，Augmedix 股票随后从纳斯达克退市。对于法语投资者而言，Augmedix 最好被视为一个以快速行业整合为标志的美国数字健康案例研究，而不是一个仍在上市的独立股票故事。
